Zhang XJ - Search Results

1

Targeting nuclear factor erythroid 2-related factor 2-regulated ferroptosis to treat nervous system diseases.

Huang YQ, Huang ZW, Zhang XJ. Huang YQ, et al. Among authors: zhang xj. World J Clin Cases. 2024 Nov 26;12(33):6655-6659. doi: 10.12998/wjcc.v12.i33.6655. World J Clin Cases. 2024. PMID: 39600481 Free PMC article.

2

Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation.

Peng T, Zhang X, Huang Y, Zhao Z, Liao Q, Xu J, Huang Z, Zhang J, Wu CY, Pan X, Wu C. Peng T, et al. Sci Rep. 2017 May 2;7:46517. doi: 10.1038/srep46517. Sci Rep. 2017. PMID: 28462948 Free PMC article.

3

Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement.

Zhao Z, Huang Z, Zhang X, Huang Y, Cui Y, Ma C, Wang G, Freeman T, Lu XY, Pan X, Wu C. Zhao Z, et al. Expert Opin Drug Deliv. 2018 May;15(5):443-457. doi: 10.1080/17425247.2018.1450865. Epub 2018 Mar 13. Expert Opin Drug Deliv. 2018. PMID: 29532682

4

Chitosan-based binary dry powder inhaler carrier with nanometer roughness for improving in vitro and in vivo aerosolization performance.

Huang Y, Huang Z, Zhang X, Zhao Z, Zhang X, Wang K, Ma C, Zhu C, Pan X, Wu C. Huang Y, et al. Drug Deliv Transl Res. 2018 Oct;8(5):1274-1288. doi: 10.1007/s13346-018-0564-y. Drug Deliv Transl Res. 2018. PMID: 30112607

5

Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation.

Huang Z, Huang Y, Ma C, Ma X, Zhang X, Lin L, Zhao Z, Pan X, Wu C. Huang Z, et al. Mol Pharm. 2018 Dec 3;15(12):5521-5533. doi: 10.1021/acs.molpharmaceut.8b00668. Epub 2018 Nov 20. Mol Pharm. 2018. PMID: 30252486

6

Moisture-Resistant Co-Spray-Dried Netilmicin with l-Leucine as Dry Powder Inhalation for the Treatment of Respiratory Infections.

Cui Y, Zhang X, Wang W, Huang Z, Zhao Z, Wang G, Cai S, Jing H, Huang Y, Pan X, Wu C. Cui Y, et al. Pharmaceutics. 2018 Dec 1;10(4):252. doi: 10.3390/pharmaceutics10040252. Pharmaceutics. 2018. PMID: 30513738 Free PMC article.

7

Modified-release oral pellets for duodenum delivery of doxycycline hyclate.

Huang Y, Huang Z, Wu M, Liu Y, Ma C, Zhang X, Zhao Z, Bai X, Liu H, Wang L, Pan X, Wu C. Huang Y, et al. Drug Dev Res. 2019 Nov;80(7):958-969. doi: 10.1002/ddr.21575. Epub 2019 Jul 29. Drug Dev Res. 2019. PMID: 31359488

8

Smart phase transformation system based on lyotropic liquid crystalline@hard capsules for sustained release of hydrophilic and hydrophobic drugs.

Zhang X, Xiao Y, Huang Z, Chen J, Cui Y, Niu B, Huang Y, Pan X, Wu C. Zhang X, et al. Drug Deliv. 2020 Dec;27(1):449-459. doi: 10.1080/10717544.2020.1736210. Drug Deliv. 2020. PMID: 32157918 Free PMC article.

9

Calcitriol tablets with hybrid lipid-based solid dispersions with enhanced stability and content uniformity.

Yue X, Cui Y, Yuan T, Huang Z, Huang Y, Zhang X, Wang C, Wang G, Liang R, Liu C, Pan X, Wu C. Yue X, et al. Pharm Dev Technol. 2020 Sep;25(7):899-907. doi: 10.1080/10837450.2020.1760297. Epub 2020 May 12. Pharm Dev Technol. 2020. PMID: 32324081

10

Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery.

Huang Z, Huang Y, Wang W, Fu F, Wang W, Dang S, Li C, Ma C, Zhang X, Zhao Z, Pan X, Wu C. Huang Z, et al. J Control Release. 2020 Sep 10;325:206-222. doi: 10.1016/j.jconrel.2020.06.004. Epub 2020 Jul 1. J Control Release. 2020. PMID: 32619747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,658 results

Search Page

Filters